Evidence map›Paper›PMID 41154983›Full record

ArticleInternational journal of environmental research and public health2025

Feasibility and Acceptability of Assessing Personal Care Product Use and Exposure to Endocrine-Disrupting Chemicals Among Black and Hispanic Breast Cancer Survivors: A Pilot Study.

Erin Speiser, Peggy-Ita Obeng-Nyarkoh, Wanting Zhai, Adana A M Llanos, Jennifer Hicks, Chiranjeev Dash, Lucile L Adams-Campbell, Gail E Starr, Traci N Bethea

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Erin SpeiserThe Deirdre Imus Environmental Health Center®, Hackensack University Medical Center, Hackensack, NJ 07601, USA.ORCID 0000-0002-3306-0873
Peggy-Ita Obeng-NyarkohGeisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.ORCID 0009-0001-6685-985X
Wanting ZhaiCancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC 20057, USA.
Adana A M LlanosDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.ORCID 0000-0001-9954-9121
Jennifer HicksOffice of Minority Health and Health Disparities Research, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC 20003, USA.
Chiranjeev DashCancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC 20057, USA.
Lucile L Adams-CampbellCancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC 20057, USA.ORCID 0000-0002-3444-3884
Gail E StarrThe Betty Torricelli Institute for Breast Care, Hackensack University Medical Center, Hackensack, NJ 07601, USA.ORCID 0009-0005-1259-7208
Traci N BetheaCancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC 20057, USA.ORCID 0000-0003-3205-2078

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI Habtom W Ressom · 1990 to 2026
$71.5M
An assessment of whether aspirin and/or vitamin D improves breast cancer outcomes in Black women and the modifying effect of genetic variantsK01CA212056 · NCI · GEORGETOWN UNIVERSITY · PI BETHEA, TRACI N. · 2017 to 2021
$656k
American Cancer Society IRG-17-177-23NCI NIH HHS K01 CA212056NCI NIH HHS P30 CA051008NIH HHS 1K01CA212056-20NIH HHS 1P30CA051008-20NIH HHS K01 CA212056: 8/1/2020-7/31/2023 and P30 CA051008: 7/1/2020-present
6 · The paper itself

Abstract

This pilot study explored the feasibility and acceptability of utilizing silicone wristbands to assess exposure to endocrine-disrupting chemicals (EDCs) among 25 Black and Hispanic breast cancer survivors recruited in Washington, DC, and Hackensack, NJ. Over half of participants (58%) were diagnosed with Stage I breast cancer and the mean age was 58 ± 9 years. Most of the 24 survey respondents (95.83%) reported that the wristband did not interfere with daily activities and few (4) removed the wristband during the 7-day data collection period, demonstrating feasibility of use. Acceptability of passive sampling via silicone wristband was high with 73.91% of survivors reporting being "very satisfied" and 21.74% reporting being "satisfied" with their experience. The wristbands were analyzed via gas chromatography mass spectrometry for approximately 1500 semi-volatile organic compounds. This untargeted approach detected sixty distinct chemicals with an average of 21.8 per wristband. Personal care product, flame retardant, commercial product, and pesticide chemical classifications were detected in every wristband and frequently detected chemicals included biologically active compounds with potential genotoxic or endocrine-disrupting effects. This study demonstrates the feasibility of use and technical feasibility, as well as the acceptability, of utilizing silicone wristbands to assess exposure to semi-volatile organic compounds, including EDCs, among Black and Hispanic breast cancer survivors and lays the foundation towards engaging diverse cancer survivors in environmental health research.

Indexed as

Breast NeoplasmsCancer SurvivorsCosmeticsEndocrine DisruptorsEnvironmental ExposureEnvironmental MonitoringAdultAgedBlack or African AmericanDistrict of ColumbiaFeasibility StudiesFemaleHispanic or LatinoHumansMiddle AgedPilot ProjectsCosmeticsEndocrine DisruptorsBlackbreast cancercancer survivorshipendocrine-disrupting chemicalsenvironmental healthHispanicpersonal care products

Identifiers

PMID41154983
PMCPMC12563251

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.